Skip to content

Get With The Guidelines-Heart Failure Registry

Get With The Guidelines-Heart Failure Registry

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02693509
Enrollment
128026
Registered
2016-02-26
Start date
2005-01-31
Completion date
2040-01-31
Last updated
2025-01-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Failure

Brief summary

Get With The Guidelines-Heart Failure is designed to improve the quality of care in patients hospitalized with heart failure. The program aims to help ensure that eligible patients are initiated on guideline recommended therapies and receive appropriate counseling prior to hospital discharge.

Detailed description

Get With The Guidelines-Heart Failure was initiated in 2005 with over 500 U.S. hospitals participating is designed to improve the quality of care in patients hospitalized with heart failure. The program aims to help ensure that eligible patients are initiated on guideline recommended therapies and receive appropriate counseling prior to hospital discharge. Peer-reviewed research(with over 35 manuscripts) has demonstrated that through participating in Get With The Guidelines-Heart Failure, hospitals will provide equitable care (regardless of race, ethnicity, age, or gender), the importance of scheduled physician follow-up after heart failure hospital discharge, the value in device-support as necessary for the acute heart failure patient, and many other significant findings. Achievement measures tracked through Get With The Guidelines-Heart Failure: * Angiotensin converting enzyme inhibitor (ACEI) and angiotensin receptor blocker (ARB) at discharge * Evidence-based specific beta blockers * Measure left ventricular function * Post-discharge appointment for heart failure patients Quality Measures tracked through Get With The Guidelines-Heart Failure: * Mineralocorticoid receptor antagonist at discharge * Aldosterone antagonist at discharge * Anticoagulation for atrial fibrillation * Hydralazine nitrate at discharge * DVT prophylaxis * CRT-D or CRT-P placed or prescribed at discharge * ICD counseling, or ICD placed or prescribed at discharge * Influenza vaccination during flu season * Pneumococcal vaccination * Follow-up visit within 7 days or less * Lab monitoring follow-up * SGLT-2 inhibitor at discharge * Defect-free care for quadruple therapy medication for patients with heart failure with reduced ejection fraction * Direct-acting oral anticoagulant at discharge for non-valvular atrial fibrillation or atrial flutter patients Additional measures collected by Get With The Guidelines-Heart Failure can be viewed at: http://www.heart.org/idc/groups/heart-public/@wcm/@private/@hcm/@gwtg/documents/downloadable/ucm\_310967.pdf

Interventions

OTHERGWTG Heart Failure program

Evidence based guideline recommended therapies and counseling prior to hospital discharge

Sponsors

American Heart Association
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Age
18 Years to 125 Years
Healthy volunteers
Yes

Inclusion criteria

* Patients hospitalized with congestive heart failure.

Exclusion criteria

* Patients who do not have congestive heart failure, * Patients under age of 18, * Patients not admitted as inpatients.

Design outcomes

Primary

MeasureTime frameDescription
30 day readmission rate30 days post discharge from hospitalPercent of index encounters where there is a readmission within 30 days
60 day readmission rate60 days post discharge from hospitalPercent of index encounters where there is a readmission within 60 days
90 day readmission rate90 days post discharge from hospitalPercent of index encounters where there is a readmission within 90 days

Countries

United States

Contacts

Primary ContactAmy Bennett, JD
amy.bennett@heart.org214-706-4881
Backup ContactChristine Rutan
Christine.Rutan@heart.org214-706-4881

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 11, 2026